PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Evolving Therapies in Multiple Sclerosis: BTK Inhibitors
Visit https://www.peervoice.com/HGK860 to view the entire programme with slides. After completing “Evolving Therapies in Multiple Sclerosis: BTK Inhibitors”, participants will be able to: Describe the role of Bruton's tyrosine kinase (BTK) and immune cells in multiple sclerosis (MS) pathogenesis; Explain the limitations of current B-cell therapeutic strategies and the rationale for the investigation into BTK inhibitors; Summarise the most recent clinical data for BTK inhibitors in patients with MS.